XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Common Stock and Stockholders' Equity (Tables)
3 Months Ended
Apr. 30, 2024
Equity [Abstract]  
Summary of Shares of Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance are as follows:
April 30, 2024
Outstanding stock options and unvested RSUs and PSUs15,595,062 
Available for future stock option, RSU, and PSU grants19,846,670 
Available for Employee Stock Purchase Plan (“ESPP”)4,297,539 
Total common stock reserved at April 30, 202439,739,271 
Schedule of Stock Option Activity
Stock option activity is as follows:
Number of
Shares
Weighted
Average Exercise
Price
Weighted
Average
Remaining
Contractual Term
Aggregate
Intrinsic Value
(in thousands)
Outstanding at January 31, 20244,875,025 $10.29 4.4 years$68,151 
Granted— $— 
Exercised(41,875)$6.94 
Canceled(12,289)$13.30 
Outstanding at April 30, 20244,820,861 $10.31 4.1 years$50,306 
Vested as of April 30, 20244,718,085 $9.88 4.0 years$50,064 
Schedule of Restricted Stock Unit Activity
A summary of the Company’s RSU activity and related information is as follows:
Number of RSUsWeighted
Average Grant Date Fair Value Per Share
Outstanding at January 31, 20247,412,056 $31.08 
Granted2,924,763 $21.63 
Vested(783,267)$30.73 
Forfeited or canceled(342,977)$29.79 
Outstanding at April 30, 20249,210,575 $28.17 
Schedule of Restricted Stock Unit Activity
A summary of the Company’s PSU activity and related information is as follows:
Number of PSUsWeighted
Average Grant Date Fair Value Per Share
Outstanding at January 31, 2024541,992 $35.08 
Granted(1)
781,813 $21.62 
Vested(9,050)$41.17 
Forfeited or canceled(3,280)$41.88 
Performance adjustment for 2023 PSU Awards
(529,662)$34.98 
Outstanding at April 30, 2024781,813 $28.14 
(1)This amount represents awards granted at 100% attainment.
Schedule of Stock-based Compensation Expense
Stock-based compensation expense included in the Company’s condensed consolidated statements of operations is as follows:
Three Months Ended April 30,
20242023
(in thousands)
Cost of revenue$1,756 $1,876 
Research and development11,222 10,101 
Sales and marketing7,947 5,951 
General and administrative12,015 9,617 
Total$32,940 $27,545